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Biopositive Effects of Low-Dose UVB on Epidermis:
Coordinate Upregulation of Antimicrobial Peptides
and Permeability Barrier Reinforcement
Seung P. Hong1, Min J. Kim1, Min-young Jung1, Hyerin Jeon1, Jawoong Goo1, Sung K. Ahn1, Seung H. Lee2,
Peter M. Elias3 and Eung H. Choi1,4
Whereas high-dose ultraviolet B (UVB) is detrimental to the epidermal permeability barrier, suberythemal doses
of UVB are used to treat atopic dermatitis (AD), which is characterized by defective permeability barrier and
antimicrobial function. As epidermal permeability barrier and antimicrobial peptide (AMP) expression are
coregulated and interdependent functions, we hypothesized that suberythemal doses of UVB exposure could
regulate AMP expression in parallel with permeability barrier function. Hairless mice were exposed to
40mJ cm2 UVB (about 1/2 minimal erythema dose) daily for 1 or 3 days. Twenty-four hours after the last
exposure, epidermal barrier function was assessed and skin specimens were taken for western blotting,
immunohistochemistry, and quantitative reverse transcription-PCR for mouse b-defensin (mBD)-2, mBD3 and
cathelin-related antimicrobial peptide (CRAMP). mRNA levels of the vitamin D receptor (VDR), 1a-hydroxylase
and key epidermal lipid synthetic enzymes were also quantified. After 3 days of UVB exposure, acceleration of
barrier recovery and augmentation in expression of epidermal differentiation markers (for example, involucrin
and filaggrin) occurred in parallel with increased mBD2, mBD3, and CRAMP expression at both the mRNA and
protein level. VDR, 1a-hydroxylase, and the major epidermal lipid synthetic enzymes were also upregulated.
When an inhibitor of 1a, 25 dihydroxyvitamin D3 formation, ketoconazole, was applied immediately after UVB
exposure, the cutaneous vitamin D system was inhibited, which in turn blocked epidermal lipid synthesis, AMP
expression, and permeability barrier homeostasis, suggesting that the beneficial effect of low-dose UVB
depends, at least in part, on activation of the cutaneous vitamin D system. Our results provide new insights into
the mechanisms whereby low-dose UVB comprises effective therapy for AD.
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INTRODUCTION
Atopic dermatitis (AD) is characterized by abnormal immune
responses, impaired barrier function, and an increased
susceptibility to bacterial and viral infections. Expression
levels of both human b-defensin (hBD)-2 and LL-37 are
significantly decreased in lesional skin (Ong et al., 2002), that
is, upregulation does not occur as in other inflammatory or
infectious dermatoses (de Jongh et al., 2005). Accordingly,
the increased susceptibility to colonization and invasion by
microbial pathogens that occurs in AD patients could be
related to a combined deficit in permeability barrier function,
coupled with low antimicrobial peptide (AMP) expression.
Accordingly, stratum corneum expresses a number of AMPs,
such as b-defensins, cathelicidins, RNase 7, and psoriasin,
which both recognize and kill invading microorganisms,
while functioning as distal sensors of the innate immune
system (Elias, 2007). Two important AMP families are the
b-defensins (hBD1, 2, 3, and 4) and the cathelicidin carboxy-
terminal fragment (LL-37), whose murine homologs include
mBD3 (hBD2) and cathelin-related antimicrobial peptide
(CRAMP) (LL-37), respectively. Two of these AMPs, hBD2
and LL-37, are expressed at low levels in normal skin, but
higher levels are induced in wounded and/or diseased skin
(de Jongh et al., 2005), with the important exception of AD
(Ong et al., 2002). Both hBD2 and LL-37 are copackaged
along with lipids within lamellar bodies, and apparently
delivered to the stratum corneum interstices by lamellar body
secretion (Oren et al., 2003; Braff et al., 2005). Acute
permeability barrier perturbations also upregulate mBD3 and
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CRAMP expression (Aberg et al., 2008). Such barrier
perturbations initiate a cytokine cascade that upregulates
not only permeability barrier repair, but also hBD2 genera-
tion (Liu et al., 2002). In contrast, LL-37 expression is not
regulated by cytokines, but rather by ligands of the vitamin
D3 receptor (Weber et al., 2005; Elias, 2007), which also are
known stimulators of epidermal differentiation (Bikle, 2004).
Notably, certain AMP (that is, LL-37) is essential for the
homeostasis of the permeability barrier (Aberg et al., 2008).
Together, these results suggest a close interrelationship
between the permeability and antimicrobial barriers that
could be regulated in part through inflammatory cytokine
signaling (Elias and Choi, 2005; Elias, 2007).
Although narrowband UBV or UVA phototherapy is a
mainstay of treatment, both natural and artificial ultraviolet B
(UVB) irradiation are commonly employed in the treatment of
AD (Jekler and Larko, 1988; Wulf and Bech-Thomsen, 1998).
Although the benefits of UVB are attributed generally to its
immunomodulating activity, we hypothesized here that
suberythemal UVB therapy could improve permeability
barrier function and antimicrobial defense in parallel. In
contrast, single, high doses of UVB (for example,X4 minimal
erythema dose (MED)) instead are known to exert detrimental
effects on permeability barrier function (Haratake et al.,
1997; Holleran et al., 1997; Takagi et al., 2004). Moreover,
low-dose UV phototherapy is useful for the treatment of
various skin disorders, including psoriasis and AD (Jekler and
Larko, 1988; Wulf and Bech-Thomsen, 1998; Leenutaphong
et al., 2000). Our hypothesis is also supported by the
observations that (1) 1.5 MED UVB-irradiated skin becomes
relatively resistant to irritants (Lehmann et al., 1991) and (2)
irradiation with suberythemal doses of UVB stimulates
epidermal ceramide production (Wefers et al., 1991; Farrell
et al., 1998). Recently, repeated low-dose UVB has also been
demonstrated to provide a limited protective effect against
subsequent UV-induced inflammatory responses (Narbutt
et al., 2007). As AMP expression is regulated by UVB
irradiation (Seo et al., 2001; Mallbris et al., 2005; Gambichler
et al., 2006), we also hypothesized that expression of hBD2
and LL-37, the two barrier-linked AMPs that are decreased in
AD, could be upregulated by suberythemal UVB, further
accounting for its therapeutic benefits.
UVB also promotes production of biologically active
1a,25-dihydroxy-vitamin D3 [1,25(OH)2D3], which has
various roles including induction of differentiation and
regulation of apoptosis, in keratinocytes as well as immuno-
modulatory effects in the skin (Lehmann, 2005). The benefits
of vitamin D3 could be related to both its known effects on
epidermal differentiation and lipid synthesis (Bikle et al.,
2004a, b), coupled with enhanced innate immunity (that is,
increased toll-like receptor and AMP expression) (Mallbris
et al., 2005; Weber et al., 2005; Schauber et al., 2007). We
further hypothesized that vitamin D3 could provide a link
between the permeability barrier and antimicrobial barriers,
hypothesizing that low-dose UVB irradiation could improve
permeability barrier function in parallel with increased AMP
expression, mediated through increased cutaneous vitamin
D3 production. To date, there are no published studies that
have assessed the effects of suberythemal UVB on either
permeability barrier homeostasis or epidermal AMP expres-
sion. Herein, we report that UVB irradiation upregulates
permeability barrier function and AMP expression in parallel
in hairless mouse epidermis, and that cutaneous vitamin D3
plays a major role in mediating this process.
RESULTS
Low-dose UVB irradiation for 3 days improves barrier recovery
We first delineated the effects of suberythemal (low-dose)
UVB exposure on epidermal permeability barrier homeo-
stasis. Hairless mice (n¼6 in each group) were exposed
to 40mJ cm2 UVB (about 1/2 MED) once daily for either 1 or
3 days. Control mice were sham-irradiated with fluorescent
light for same exposure time. There were no significant
differences in basal transepidermal water loss (TEWL) among
the 3-day or 1-day UVB and control groups (Figure 1a).
However, after previous UVB irradiation for 3 days,
tape-stripped skin showed significantly accelerated barrier
recovery in comparison with control mouse skin 3 hours after
tape-stripping (P¼0.011; Figure 1b). In contrast, there were
no significant differences in barrier recovery rates following a
single UVB dose versus sham light-exposed mice (P¼0.090,
P¼0.052, respectively; Figure 1b). Thus, repeated, short-
term exposure to low-dose UVB significantly accelerates the
kinetics of barrier recovery after acute insults.
Low-dose UVB irradiation augments AMP expression at protein
and mRNA level
As the expressions of mBD3 and CRAMP change in parallel
with permeability barrier status (Aberg et al., 2008), we next
assessed whether the expression of mBD2, mBD3, and
CRAMP protein increase in murine epidermis after low-dose
UVB exposure. Epidermis from 3-day UVB-exposed mice
demonstrated a marked increase in immunostaining for
mBD2, mBD3, and CRAMP than either control or 1-day
UVB-exposed animals. Moreover, the UVB-induced increase
in AMP expression was largely localized to the outer
epidermis (Figure 2). These immunohistochemical data were
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Figure 1. Low-dose UVB irradiation for 3 days increases barrier recovery
rate after acute permeability barrier disruption by tape-stripping compared
with sham light, without affecting basal TEWL. Hairless mice were exposed
to 40mJ cm2 UVB once daily for 1 or 3 days. Sham light was exposed on
control group. (a) Basal TEWL rates and (b) barrier recovery rates following
tape-stripping were measured. Statistical analysis was performed using an
unpaired Student’s t-test. Results are expressed as mean±SEM; n¼ 6 in each
group. (dotted horizontal line: upper limit of normal range; solid horizontal
line: control level).
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confirmed by western blot analysis, which showed that levels
of mBD2, mBD3, and CRAMP expression increased after
3 days of UVB exposure in comparison with either control or
1-day exposure (Figure S1). These results show that repeated
suberythemal doses of UVB stimulate expression of AMP
homologous of hBD2 and LL-37 in the outer epidermis of
murine skin.
We next examined whether the changes in mBD2, mBD3,
and CRAMP protein reflect increased expression at the
transcriptional level, by assessing changes in epidermal
RNA expression. Total RNA was extracted from epidermis
and reverse-transcribed by standard methods, and expression
was quantified by real-time reverse transcription-PCR (RT-
PCR). Increased mRNA expression of mBD2, mBD3, and
CRAMP was observed in 3-day UVB-irradiated mice com-
pared with sham-light-irradiated controls (Figure S2a).
Expression of mBD2 and CRAMP mRNA was more than
twofold higher (216 and 248%, respectively) in 3-day UVB-
irradiated epidermis than in controls, with the upregulation of
mBD2 even more significant than for CRAMP (Figure S2b). In
contrast, one-day UVB exposure did not upregulate either of
these AMPs (Figure S2a). These results confirm that the UVB-
induced increase in protein levels is reflected by a previous or
concurrent increase in mRNA expression.
Low-dose UVB irradiation stimulates the cutaneous vitamin D3
system
To ascertain whether 3-day exposure to low-dose UVB
modulates expression of the cutaneous vitamin D3 system,
which is known to regulate LL-37 expression, epidermal
mRNA levels of the vitamin D receptor (VDR) and 1a-
hydroxylase were quantified with real-time PCR. Sixteen
hours after the last UVB exposure, there was a significant
increase in mRNA for both of these genes, although the
increase in 1a-hydroxylase was less marked than for the VDR
(mean levels of vitamin VDR and 1a-hydroxylase mRNA
increased by 604 and 270%, respectively, Figure 3a). Six
hours after the last exposure, no significant differences in
these genes were found in comparison with control groups
(Figure 3a). Interestingly, mRNA levels of the vitamin D3
system were much more increased after 16 hours than after
CRAMP neg. controlCRAMP controlCRAMP UVB (1 day)CRAMP UVB (3 days)
mBD3 UVB (3 days) mBD3 UVB (1 day) mBD3 control mBD3 neg. control
mBD2 neg. controlmBD2 controlmBD2 UVB (1 day)mBD2 UVB (3 days)
Figure 2. Low-dose UVB exposure increases expression of antimicrobial peptides in murine epidermis. Hairless mice (n¼6 in each group) were exposed to
40mJ cm2 UVB once daily for either (a, e, i) 3 days or (b, f, j) 1 day. (c, g, k) Sham light was exposed on control group. (d, h, l) Negative controls were the skin
samples stained without primary antibodies for mBD2, mBD3 and CRAMP. At 24 hours after the last irradiation, skin biopsies were taken and prepared for
paraffin blocks. Immunohistochemical stains with diaminobenzidine (DAB) were used for (a–d) mBD2, (e–h) mBD3 and (i–l) CRAMP. Bar¼40 mm.
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Figure 3. Low-dose UVB irradiation stimulates the cutaneous vitamin D3
system, but this effect is inhibited by ketoconazole. Hairless mice (n¼3 in
each group) were exposed to 40mJ cm2 UVB once daily for 3 days. Sham
light was exposed on control group. (a) At 6 or 16 hours after the last UVB
exposure, expression of mRNA was quantified using a Rotor-Gene 3000
instrument system (Corbett Life Science) from the epidermis of dorsal skin.
Relative mRNA expressions of vitamin D receptor (VDR) and 1a-hydroxylase
represent the activity of cutaneous vitamin D3 system. (b) Immediately after
each exposure, ketoconazole 2% cream or vehicle cream was applied to the
irradiated dorsal skin. At 16 hours after the last exposure, expression of mRNA
was quantified. Results are shown relative to the control mRNA levels.
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6 hours. These results indicated that low-dose UVB exposure
results in upregulation of the cutaneous vitamin D3 system.
Blockade of the cutaneous vitamin D system reverses the
benefits of low-dose UVB on epidermal permeability barrier
function and AMP expression
To elucidate whether the beneficial effects of low-dose UVB
are mediated by UVB-induced activation of the cutaneous
vitamin D3 system, we applied ketoconazole cream (2%)
immediately after UVB exposure to block epidermal synthesis
of active vitamin D3 [(1,25(OH)2D3)]. There was a significant
decrease in mRNA for VDR and 1a-hydroxylase (54
and 46%, respectively) in the ketoconazole- versus vehicle-
treated epidermis, which indicated suppression of intra-
cutaneous vitamin D3 activity (Figure 3b). The mean basal
TEWL in ketoconazole-treated mice was 14.4 gm2 hour1
(significant increase over the hydrobase-treated group was
10.3 gm2 hour1) (Figure 4a). The kinetics of barrier
recovery also was slightly delayed in the ketoconazole-
versus vehicle-treated mice at 3 hours (P¼0.09) and 6 hours
(P¼0.09) (Figure 4b). In control, epidermal immunostaining
of mBD2, mBD3, and CRAMP was less intense in ketocona-
zole-treated than in vehicle-treated mice (Figure 5). Together,
these results indicate that the benefits of suberythemal doses
of UVB on the barrier and antimicrobial defense are mediated
by the cutaneous vitamin D3 system.
Low-dose UVB irradiation increases both epidermal lipid
synthetic enzymes and epidermal differentiation markers
We next assessed the basis for the UVB-induced improve-
ment in barrier function. The changes in lipid synthetic
enzymes, HMG-CoA reductase (HMG-CoA), fatty acid
synthase (FAS), and serine-palmitoyl transferase (SPT), paral-
leled changes in the vitamin D3 system (Figure 3a). The
mRNA levels of the rate-limiting enzymes for epidermal lipid
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Figure 4. Inhibition of active vitamin D3 synthesis by ketoconazole
weakened the effect of low-dose UVB on the permeability barrier function.
Hairless mice were exposed to 40mJ cm2 UVB once daily for 3 days. Sham
light was exposed on control group. Immediately after each UVB irradiation,
4mg/cm2 of 2% ketoconazole cream (Nizoral, Janssen) or vehicle cream
(hydrobase) was topically applied to the irradiated dorsal skin. (a) Basal TEWL
and (b) barrier recovery rates after acute barrier perturbation with tape
stripping were measured at 16 hours after the last irradiation. Statistical
analysis was performed using an unpaired Student’s t-test. Results are
expressed as mean±SEM; n¼5 in each group.
CRAMP neg. controlCRAMP UVB (3 days) + ketoconazoleCRAMP UVB (3 days) + vehicle
mBD3 UVB (3 days) + vehicle
mBD2 UVB (3 days) + vehicle
mBD3 UVB (3 days) + ketoconazole
mBD2 UVB (3 days) + ketoconazole
mBD3 neg. control
mBD2 neg. control
Figure 5. Inhibition of active vitamin D3 synthesis by ketoconazole diminished the effect of low-dose UVB on the epidermal expression of antimicrobial
peptides. Hairless mice (n¼ 3 in each group) were exposed to 40mJ cm2 UVB once daily for 3 days. Immediately after every exposure, (b, e, h) ketoconazole
2% cream or (a, d, g) vehicle cream was applied to irradiated dorsal skin. At 16 hours after the last irradiation, skin biopsies were taken and prepared for paraffin
blocks. Immunohistochemical analysis was performed using DAB to stain (a–c) mBD2, (d–f) mBD3, and (g–i) CRAMP. (c, f, i) Skin immunostained for mBD2,
mBD3, and CRAMP without primary antibody. Bar¼40 mm.
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synthesis such as FAS, SPT, and HMG-CoA increased by 340,
420, and 341%, respectively, at 16 hours (Figure 6a). Yet, at
6 hours, there was no significant increase in any of these
enzymes. mRNA levels of the rate-limiting enzymes for the
epidermal lipid synthetic enzymes, including FAS, SPT, and
HMG-CoA, also significantly decreased in ketoconazole-
treated epidermis (by 49.7, 70.4, and 52.2%, respectively,
Figure 6b).
We next determined whether low-dose UVB induces the
changes in the expression of two epidermal differentiation-
related proteins, involucrin and filaggrin. Immunohisto-
chemical staining for both of these proteins increased in
the epidermis of suberythemal UVB-exposed mice without
the concurrent development of epidermal hyperplasia
(Figure 7). The 3-day irradiated group showed more promi-
nent upregulation of involucrin and filaggrin than did 1-day-
irradiated mice. These results indicate that UVB regulates not
only epidermal lipid synthesis, but also epidermal differen-
tiation, which provide a further mechanism for improved
epidermal permeability and antimicrobial barrier function.
DISCUSSION
Owing to the apparent importance of barrier dysfunction
and impaired antimicrobial defense in the pathogenesis of
AD, we assessed here whether barrier function and AMP
expression are inducible by repeated low-dose UVB exposure
in vivo. Our results from real-time RT-PCR, western blot
and immunohistochemical staining show that the expression
of mBD2, mBD3, and CRAMP are markedly upregulated
by 1/2 MED (40mJ cm2) of UVB irradiation daily over
3 consecutive days. Previous studies reported that a single
dose of UVB upregulates expression of both hBD1 and hBD2
in human keratinocytes (Seo et al., 2001), and a single MED
dose of UVB upregulates hCAP18 mRNA in human skin
(Mallbris et al., 2005). In contrast, a 6-week course of
narrowband UVB phototherapy with dose increment led to
a decrease in cutaneous levels of hBD2 in patients with
AD, whereas hBD3 did not change (Gambichler et al., 2006).
However, these results cannot be compared with ours,
because Gambichler et al. evaluated AMP levels in full-
thickness skin.
The molecular signaling mechanisms by which expression
of AMP could be upregulated by UVB exposure remain
poorly understood. b-Defensins are regulated by a variety of
cytokines, whereas recent studies have shown that 1a,25-
dihydroxyvitamin D3 [1,25(OH)2D3] upregulates cathelicidin
expression (Wang et al., 2004; Mallbris et al., 2005; Weber
et al., 2005; Schauber et al., 2007). It is well known that
keratinocytes possess the capacity to synthesize a biologically
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Figure 6. Low-dose UVB irradiation increases both epidermal lipid synthetic
enzymes, but this effect is inhibited by ketoconazole also. (a) At 6 or 16 hours
after the last UVB exposure, mRNA expression of rate-limiting enzymes of
epidermal lipid synthesis including fatty acid synthase (FAS), serine-palmitoyl
transferase (SPT), and HMG-CoA reductase (HMG-CoA) (b) was quantified
using a Rotor-Gene 3000 instrument system (Corbett Life Science) from
the epidermis of dorsal skin. (b) Immediately after each exposure,
ketoconazole 2% cream or vehicle cream was applied to irradiated
dorsal skin. At 16 hours after the last exposure, expression of mRNA was
quantified. Results are shown relative to the control mRNA levels.
Involucrin neg. controlInvolucrin controlInvolucrin UVB (1 day)Involucrin UVB (3 days)
Filaggrin UVB (3 days) Filaggrin UVB (1 day) Filaggrin control Filaggrin neg. control
Figure 7. UVB exposure increases expression of differentiation markers in murine epidermis. (a–d) Filaggrin and (e–h) involucrin were immunostained using
DAB (n¼ 3 in each group). (a, e) Three-day UVB irradiated group showed more prominent expression compared with either (c, g) 3-day sham-light-irradiated
control or (b, f) 1-day UVB-irradiated group. Negative controls were the skin samples stained without primary antibodies for (d) filaggrin and (h) involucrin.
Bar¼40 mm.
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active form of vitamin D3, 1,25(OH)2D3, through their own
1a-hydroxylase (Bikle et al., 2004a; Lehmann, 2005). But this
pathway of 1,25(OH)2D3 production can be blocked by
topical applications of ketoconazole, which inhibits cyto-
chrome P450-dependent enzymes, such as the 1a-hydro-
xylase (Lehmann et al., 2003). Maximum cutaneous vitamin
D3 production after UVB exposure occurs at approximately
10–20% of the original epidermal 7-dehydrocholesterol
concentration, a limit achieved with suberythemogenic UV
exposures (Holick, 1981). As a result, a small amount of UVB
exposure should suffice to generate synthesis sufficient
vitamin D3 to impact downstream events in epidermis.
Vitamin D action in peripheral tissues, such as the epider-
mis, is mediated by the VDR. Accordingly, the upregulation
of epidermal VDR levels likely predicts enhanced effects
of either exogenous/topical or intracutaneously generated
1,25(OH)2D3 in epidermis (Solvsten et al., 1997; Mallbris
et al., 2005). Our study showed that mRNA levels for both the
VDR and 1a-hydroxylase are upregulated by 3-day UVB
exposure with suberythemal dose, and conversely, down-
regulated by blockade of vitamin D generation by ketocona-
zole. Hence, it is likely that considerable active 1,25(OH)2D3
is produced in response to suberythemal UVB, but ketoco-
nazole likely lowered vitamin D3 levels. Therefore, it is
plausible that AMP upregulation induced by low-dose UVB
is mediated through cutaneous production of 1,25(OH)2D3,
the most active form of vitamin D3.
We also showed that suberythemal doses of UVB irradi-
ation improved permeability barrier homeostasis. In previous
studies, permeability barrier was disrupted in murine
epidermis with high doses of UVB irradiation (Haratake
et al., 1997; Holleran et al., 1997), which was followed by a
delayed increase in epidermal lipid synthesis as well as
accelerated production and secretion of lamellar body,
which eventually restore permeability barrier homeostasis
(Holleran et al., 1997). In our study, only 1/2 MED of UVB
was employed daily. Although this dose provokes neither
clinically evident inflammation nor barrier disruption, an
increase in mRNA levels for HMG-CoA, FAS, and SPT as key
synthetic enzymes of cholesterol, fatty acid, and sphingolipid
resulted, which could account for the ability of low-dose
UVB to improve permeability barrier homeostasis.
Downstream effects of increased endogenous vitamin D3
production could also explain, in part, the benefits of low-
dose UVB for barrier function. Previous studies have shown
that 1,25(OH)2D3 likely plays an important role in the
generation and maintenance of the permeability barrier
and in epidermal differentiation (Bikle et al., 2004a, b).
And, 1,25(OH)2D3 increases expression of major epidermal
differentiation proteins, such as involucrin, loricrin, filaggrin,
and transglutaminase, as well as stimulates cornified envel-
ope formation, which are required for optimal epidermal
differentiation and, therefore, permeability barrier home-
ostasis (Bikle et al., 2004a). Also, topical 1,25(OH)2 vitamin
D3, calcitriol increases the lipid content of murine epidermis
and counteracts the permeability barrier abnormality induced
by topical steroids (Oh et al., 2007). Our immunohistochem-
ical assessment of murine epidermis after UVB irradiation for
3 days revealed an augmentation in involucrin and filaggrin
expression, suggesting that suberythemal doses of UVB
may stimulate not only lipid synthesis, but also corneocyte
formation. Thus, low-dose UVB irradiation may result in an
overall enhancement of barrier function through a variety of
mechanisms.
Acute exposure to UV light induces a variety of cutaneous
responses that can be either beneficial or harmful. This study
clearly shows the beneficial effects of UVB, including
increased epidermal AMP expression and permeability
barrier reinforcement. Exposure dose is an important factor
in determining the effects of UVB exposure. UV-induced
DNA damage and barrier disruption increase linearly with
increasing dose (Lamaud and Schalla, 1984). Indeed,
previous studies have shown that a treatment regimen of
repeated suberythemogenic doses is more effective for AD
than conventional dose increments, in part because lower
doses of UVB could reduce UV-induced adverse effects, such
as erythema, xerosis, and inflammation, without increasing
tanning and inflammation (Wulf and Bech-Thomsen, 1998).
Our studies suggest that suberythemal doses of UVB not only
have an acceptable side-effect profile, but they also induce
beneficial effects on barrier function and antimicrobial
defense, presumably mediated by vitamin D3 production,
leading to both epidermal lipid/DNA synthesis and AMP
expression. However, further studies are needed to determine
whether the local tissue concentrations of UVB-induced
AMP are within an effective antimicrobial range, and whether
UVB exposure enhances barrier function and antimicrobial
defense in AD as well.
In conclusion, our results demonstrate beneficial effects of
low-dose UV irradiation on the skin and provide indirect
evidence for a possible connection between the epidermal
permeability barrier and antimicrobial defense, which, at
least in part, is mediated by cutaneous vitamin D3 activation.
The positive effects of low-dose UVB radiation on AMP
expression and permeability barrier homeostasis can explain
why UVB could be a useful therapeutic strategy for AD.
MATERIALS AND METHODS
Animals and UVB irradiation
Female hairless mice (8–12 weeks old) were purchased from the
animal laboratory of Yonsei University. Mice were kept under
controlled humidity (40%) and temperature (22±2 1C). All animal
experiments described in this study were conducted in accordance
with accepted standards of humane animal care, under protocols
approved by the local animal research committee at Yonsei
University Wonju College of Medicine. To observe the changes in
AMP expression after UVB irradiation, the dorsal skin of each mouse
was irradiated with 40mJ cm2 UVB, equivalent to 1/2 MED, once a
day for 1 or 3 days (n¼ 6 each for functional study; n¼ 3 each for
immunohistochemistry, western blot, and PCR studies). UVB
irradiation was delivered with Philips TL20W/12 fluorescent lamps
(Eindhoven, Netherlands) emitting 280–320 nm. One MED, pre-
viously determined using the same species, equals approximately
80mJ cm2. A control group was exposed to sham light (ordinary
fluorescent lamp, DULUX-L, Oslam Korea, Ansan, Korea) for the
same exposure time. Epidermal barrier function was assessed and
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skin specimens for analysis of epidermal AMP and differentiation
marker expression were obtained from the central dorsum 24hours
after the last exposure. Additionally, to assess the effect on cutaneous
vitamin D3 synthesis and mRNA expression of epidermal lipid
synthesis-related enzymes, dorsal skins of mouse were obtained at 6
or 16 hours after 3-day UVB exposure. Finally, to elucidate the effect
of vitamin D activated by UVB on epidermal permeability and
antimicrobial barrier, ketoconazole (known as an inhibitor of
1,25(OH)2D3 synthetic enzymes) was used. A quantity of 4mg cm
2
of a cream containing 2% ketoconazole (Nizorals, Janssen
Pharmaceutica, Titusville, NJ) or vehicle cream (hydrobase) as
control were topically applied to the skin immediately after each
UVB irradiation for 3 days as reported previously (Lehmann et al.,
2003). Functional study for permeability barrier, immunohistochem-
ical stain for AMP, and real-time RT-PCR for vitamin D system and
epidermal lipid enzyme were done as described.
Assessment of epidermal permeability barrier function
To determine whether UVB irradiation influenced the kinetics of
barrier recovery, we first assessed baseline permeability barrier
status and recovery after acute disruption by tape-stripping. The
dorsal surface of the skin was disrupted by tape-stripping with
cellophane until TEWL levels reached 50 gm2 hour1 (normal basal
TEWL o10 gm2 hour1), and measurements were repeated 3 and
6hours following tape-stripping using a Tewameter TM210 (Courage
and Khazaka, Cologne, Germany). The barrier recovery rate was
expressed as percent recovery calculated by the following formula:
(TEWL immediately after barrier disruptionTEWL at the indicated
time point)/(TEWL immediately after barrier disruptionbaseline
TEWL) 100%.
Immunohistochemical staining
For the light microscopic examination, full-thickness skin
specimens were fixed in 10% formalin solution and embedded in
paraffin. Sections of 5 mm thickness were cut and stained with
antibodies for the mBD2 (SantaCruz Technology, Santa Cruz, CA),
mBD3 (Santa Cruz), and CRAMP (Santa Cruz) as AMP, and filaggrin
(Covance, Berkeley, CA) and involucrin (Covance, CA) as differ-
entiation markers.
After deparaffinization, sections were rehydrated sequentially
with 100, 90, and 70% ethanol and incubated for 5minutes in Tris-
buffered saline to inactivate endogenous peroxidases. Samples were
then blocked for 10minutes with blocking serum solution (DAKO,
Carpinteria, CA) and incubated overnight at 41C with primary
antibody. After several washes in Tris-buffered saline, they were
incubated for 30minutes with a secondary biotinylated antibody.
Antigen was detected with the avidin–biotin complex system
(Vector, Burlingame, CA), according to the manufacturer’s instruc-
tions by using 3,30-diaminobenzidine tetrahydrochloride as sub-
strate. Then they were examined under a light microscope.
Total RNA isolation and cDNA synthesis
Skin was excised from the irradiated area. Subcutaneous fat was
removed with a surgical blade and epidermis was obtained by EDTA
(Sigma, St Louis, CA) separation. Total RNA was extracted using
Trizol reagent (Invitrogen, Carlsbad, CA), resuspended in RNase-free
water, and quantified by means of UV spectrophotometer (Perkin
Elmer Ltd, Shelton, CT). Single-stranded cDNA was prepared from
1mg of total RNA in a 20 ml reaction volume using Oligo-dT primer
(TaKaRa, Osaka, Japan), which contains 5mM MgCl2, 1mM dNTP
mixture, 1Uml1 RNase inhibitor, and 0.25U ml1 AMV reverse
transcriptase.
Classic RT-PCR
PCR was performed using primers for AMP (Table S1). Primers were
designed based on retrieved GeneBank sequences using Primer 3
software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi/, Mas-
sachusetts Institute of Technology, Cambridge, MA). Each reaction
was prepared with a Taq DNA polymerase buffer, 0.2mM of each
deoxy-NTP, 2.5mM MgCl2, 0.2mM of each forward and reverse
primer, 5Uml-1 Taq DNA polymerase, and 2 ml cDNA, in a total
volume of 20 ml. Reactions were cycled at 941C for 5minutes,
followed by 35 cycles of 1minute at 941C, 1minute at the annealing
temperature (Table S1), and for 2minutes at 721C. All RT-PCR
products were subsequently separated by electrophoresis on 2%
agarose gels containing 0.5 mgml1 ethidium bromide and visua-
lized with UV light.
Quantitative real-time PCR
Real-time RT-PCR was performed using the LightCycler instrument
(Roche Diagnostics, Mannheim, Germany) for mBD2 and CRAMP
measurement and Rotor-Gene 3000 (Corbett Life Science, Sydney,
Australia) for VDR, 1a-hydroxylase, FAS, SPT, and HMG-CoA,
according to the manufacturer’s instructions.
Briefly, real-time PCR was carried out by rapid cycling in a reaction
volume of 20ml. The reaction mixture consisted of a master mix
containing Taq DNA polymerase, dNTP mixture, and reaction buffer
(LightCycler-FastStart DNA Master Hybridization Kit) (Roche Diag-
nostics, Mannheim, Germany). In all the assays, 5mM MgCl2, 0.5mM
of each primer (Table S2), 0.2mM of each probe, and 2ml of template
cDNA were used. The amplification and detection were carried out as
follows: after an initial preincubation and denaturation step of
10minutes at 951C, amplification was performed in a three-step
cycle procedure (denaturation 951C, 10 seconds; annealing 601C,
10 seconds; and elongation 721C, 5 seconds) for 55 cycles and final
cooling. Quantification of target gene expression was obtained by
direct comparison with external standards amplified in parallel reac-
tions in the same run. The LightCycler instrument system needs two
fluorescence resonance energy transfer probes, but the Rotor-Gene
3000 system use a dual-labeled probe. Sequence-specific probes were
designed depending on each PCR machine system. The sequences of
primers and hybridization probes are listed in Table S2.
Western blot analysis
For western blotting of mBD2, mBD3, and CRAMP, the peptides
were extracted from epidermis separated from full-thickness mouse
skin. The proteins were separated by 4–12% SDS-PAGE with 3[N-
morpholino]propanesulfonic acid (MOPS) buffer (Invitrogen) and
transferred to polyvinylidene difluoride membranes. After blocking
with 5% non-fat dry milk, membranes were incubated overnight at
41C with anti-mBD2, anti-mBD3, or anti-CRAMP antibodies
(SantaCruz Technology, Santa Cruz, CA) diluted 1:200. After several
washes, peroxidase-conjugated anti-goat antibody was added (final
dilution 1:2,000) for 1 hour at room temperature. Signals was
detected using the ECL Plus Western blotting Detection System
(Amersharm, Buckinghamshire, UK).
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Statistical analysis
Data are presented as mean±SEM. The unpaired Student’s t-test was
used for analysis of differences between two groups. *Po0.05 was
considered statistically significant.
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SUPPLEMENTARY MATERIAL
Table S1. Classic RT-PCR primers of antimicrobial peptides.
Table S2. Oligonucleotide primer and hybridization probe sequences for real-
time PCR.
Figure S1. Western immunoblotting reveals increased bands of mBD2,
mBD3, and CRAMP in 3-day UVB-irradiated murine epidermis.
Figure S2. mRNA expression of mBD2, mBD3, and CRAMP are increased
after 3-day UVB exposure.
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